Literature DB >> 17209130

13q Deletion and central nervous system anomalies: further insights from karyotype-phenotype analyses of 14 patients.

Lucia Ballarati, Elena Rossi, Maria Teresa Bonati, Stefania Gimelli, Paola Maraschio, Palma Finelli, Sabrina Giglio, Elisabetta Lapi, Maria Francesca Bedeschi, Silvana Guerneri, Giulia Arrigo, Maria Grazia Patricelli, Teresa Mattina, Oriana Guzzardi, Vanna Pecile, Adalgisa Police, Gioacchino Scarano, Lidia Larizza, Orsetta Zuffardi, Daniela Giardino.   

Abstract

BACKGROUND: Chromosome 13q deletion is associated with varying phenotypes, which seem to depend on the location of the deleted segment. Although various attempts have been made to link the 13q deletion intervals to distinct phenotypes, there is still no acknowledged consensus correlation between the monosomy of distinct 13q regions and specific clinical features.
METHODS: 14 Italian patients carrying partial de novo 13q deletions were studied. Molecular-cytogenetic characterisation was carried out by means of array-comparative genomic hybridisation (array-CGH) or fluorescent in situ hybridisation (FISH).
RESULTS: Our 14 patients showed mental retardation ranging from profound-severe to moderate-mild: eight had central nervous system (CNS) anomalies, including neural tube defects (NTDs), six had eye abnormalities, nine had facial dysmorphisms and 10 had hand or feet anomalies. The size of the deleted regions varied from 4.2 to 75.7 Mb.
CONCLUSION: This study is the first systematic molecular characterisation of de novo 13q deletions, and offers a karyotype-phenotype correlation based on detailed clinical studies and molecular determinations of the deleted regions. Analyses confirm that patients lacking the 13q32 band are the most seriously affected, and critical intervals have been preliminarily assigned for CNS malformations. Dose-sensitive genes proximal to q33.2 may be involved in NTDs. The minimal deletion interval associated with the Dandy-Walker malformation (DWM) was narrowed to the 13q32.2-33.2 region, in which the ZIC2 and ZIC5 genes proposed as underlying various CNS malformations are mapped.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17209130      PMCID: PMC2597907          DOI: 10.1136/jmg.2006.043059

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Hand involvement in 13q deletion syndrome.

Authors:  S I Grindel; C Sandlin; V E Wood
Journal:  J Pediatr Orthop       Date:  1999 Sep-Oct       Impact factor: 2.324

2.  Mosaic monosomy of a neocentric ring chromosome maps brachyphalangy and growth hormone deficiency to 13q31.1-13q32.3.

Authors:  David J Amor; Lucille Voullaire; Karen Bentley; Ravi Savarirayan; K H Andy Choo
Journal:  Am J Med Genet A       Date:  2005-03-01       Impact factor: 2.802

3.  Prenatal diagnosis of 13q-syndrome in a fetus with Dandy-Walker malformation.

Authors:  Ahmet Gul; Altan Cebeci; Onur Erol; Yavuz Ceylan; Seher Basaran; Atil Yuksel
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

Review 4.  13q deletion syndrome in an adult mentally retarded patient.

Authors:  G Van Buggenhout; J Trommelen; B Hamel; J P Fryns
Journal:  Genet Couns       Date:  1999

Review 5.  The ZIC gene family in development and disease.

Authors:  I Grinberg; K J Millen
Journal:  Clin Genet       Date:  2005-04       Impact factor: 4.438

6.  Possible association of NTDs with a polyhistidine tract polymorphism in the ZIC2 gene.

Authors:  Lúcia Y Brown; Susan E Hodge; William G Johnson; Sandra G Guy; Jeffrey S Nye; Stephen Brown
Journal:  Am J Med Genet       Date:  2002-03-01

Review 7.  Is Dandy-Walker malformation associated with "distal 13q deletion syndrome"? Findings in a fetus supporting previous observations.

Authors:  Yasemin Alanay; Dilek Aktaş; Eda Utine; Beril Talim; Lütfü Onderoğlu; Melda Cağlar; Ergül Tunçbilek
Journal:  Am J Med Genet A       Date:  2005-07-30       Impact factor: 2.802

8.  Holoprosencephaly due to mutations in ZIC2: alanine tract expansion mutations may be caused by parental somatic recombination.

Authors:  L Y Brown; S Odent; V David; M Blayau; C Dubourg; C Apacik; M A Delgado; B D Hall; J F Reynolds; A Sommer; D Wieczorek; S A Brown; M Muenke
Journal:  Hum Mol Genet       Date:  2001-04-01       Impact factor: 6.150

9.  Reciprocal translocations: a trap for cytogenetists?

Authors:  Roberto Ciccone; Roberto Giorda; Giuliana Gregato; Renzo Guerrini; Sabrina Giglio; Romeo Carrozzo; Maria Clara Bonaglia; Emanuela Priolo; Carmelo Laganà; Romano Tenconi; Mariano Rocchi; Tiziano Pramparo; Orsetta Zuffardi; Elena Rossi
Journal:  Hum Genet       Date:  2005-07-23       Impact factor: 4.132

10.  Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; E Mani; G Aceti; B-M Anderlid; A Baroncini; T Pramparo; O Zuffardi
Journal:  J Med Genet       Date:  2005-11-11       Impact factor: 6.318

View more
  23 in total

1.  Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation.

Authors:  Victoria W Willard; Ibrahim Qaddoumi; Si Chen; Hui Zhang; Rachel Brennan; Carlos Rodriguez-Galindo; Matthew W Wilson; Sean Phipps
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

2.  A Rare Co-occurrence of Intestinal Malrotation and Hirschsprung's Disease in a Neonate with 13q21.31q33.1 Interstitial Deletion Including the EDNRB Gene.

Authors:  Trassanee Chatmethakul; Rozaleen Phaltas; Gwen Minzes; Jose Martinez; Ramachandra Bhat
Journal:  J Pediatr Genet       Date:  2019-01-14

3.  Deletion of Chromosome 13 due to Different Rearrangements and Impact on Phenotype.

Authors:  Fernanda T Bellucco; Hélio Rodrigues de Oliveira-Júnior; Roberta Santos Guilherme; Silvia Bragagnolo; Ana B Alvarez Perez; Vera Ayres Meloni; Maria I Melaragno
Journal:  Mol Syndromol       Date:  2019-03-06

4.  Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions.

Authors:  Diana Mitter; Reinhard Ullmann; Artur Muradyan; Ludger Klein-Hitpass; Deniz Kanber; Katrin Ounap; Marc Kaulisch; Dietmar Lohmann
Journal:  Eur J Hum Genet       Date:  2011-04-20       Impact factor: 4.246

5.  Brain abnormalities on MR imaging in patients with retinoblastoma.

Authors:  F Rodjan; P de Graaf; A C Moll; S M Imhof; J I M L Verbeke; E Sanchez; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-22       Impact factor: 3.825

Review 6.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

7.  Cytogenetic Studies of Rwandan Pediatric Patients Presenting with Global Developmental Delay, Intellectual Disability and/or Multiple Congenital Anomalies.

Authors:  Annette Uwineza; Janvier Hitayezu; Mauricette Jamar; Jean-Hubert Caberg; Seraphine Murorunkwere; Ndinkabandi Janvier; Vincent Bours; Leon Mutesa
Journal:  J Trop Pediatr       Date:  2015-10-27       Impact factor: 1.165

Review 8.  Holoprosencephaly due to numeric chromosome abnormalities.

Authors:  Benjamin D Solomon; Kenneth N Rosenbaum; Jeanne M Meck; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

9.  Developmental disorders of the midbrain and hindbrain.

Authors:  A James Barkovich
Journal:  Front Neuroanat       Date:  2012-03-06       Impact factor: 3.856

10.  Guidelines for imaging retinoblastoma: imaging principles and MRI standardization.

Authors:  Pim de Graaf; Sophia Göricke; Firazia Rodjan; Paolo Galluzzi; Philippe Maeder; Jonas A Castelijns; Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2011-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.